Is Synthetic Heparin the Solution?

St. Louis Company Accused of Distributing Untested Pharmaceutical Products

Ranbaxy Denies Any QC Issues, Data Manipulation or Adulteration of US Product

Who’s on Third? - Benchmarking Pharma Supply Chain Risk Management Practices

Heparin and the Human Face of Adverse Patient Reactions

Back to the Drawing Board: Inhaled Insulin Might Be Linked to Lung Cancer

Generics vs. Namebrand Drugs: Case Studies in Process and Ingredient Variability?

GSK and Spitzer: Schadenfreude?

Trasylol Recall May Have Come a Bit Late: 20,000 Patients Too Late, a Researcher Tells 60 Minutes